Latest Cancer: Bladder news
Perioperative Enfortumab Vedotin + Pembrolizumab Tied to Improved Outcomes With Bladder Cancer
posted February 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Color Vision Deficiency Associated With Shorter Survival for Patients With Bladder Cancer
posted January 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Meta-Analysis IDs Link Between Type 1 Diabetes and Bladder Cancer
posted December 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
Acute Cystitis Tied to Higher Risk for Urogenital Cancers
posted September 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026 .jpg)
ASH Issues Guidance on Serum Ferritin Thresholds for Diagnosing Iron Deficiency Related Articles
ASTRO Issues Guidance for Use of Radiation Therapy in Bladder Cancer 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine Monthly Specialist Briefings
Stay Connected
